Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Canadian Cancer Trials Group
American Society of Clinical Oncology
Baylor College of Medicine
Mayo Clinic
National Cancer Institute (NCI)
Hackensack Meridian Health
M.D. Anderson Cancer Center
Intensity Therapeutics, Inc.
OHSU Knight Cancer Institute
Stanford University
National Cancer Institute (NCI)
Chinese PLA General Hospital
Icahn School of Medicine at Mount Sinai
Chinook Therapeutics, Inc.
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Lytix Biopharma AS
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)